R., Moser, M., & Berland, W
FDA prescribing information: Wegovy, Ozempic, Zepbound, Mounjaro, via Drugs@FDA
A study at Penn Medicine, funded by Novo Nordisk, found that participants taking semaglutide lost an average of 16% of their starting weight and more than one-third lost 20% or more of their baseline weight during the 68-week study
Progress and Challenges in Translating the Biology of Atherosclerosis
the FTCs February 2026 Express Scripts settlement has introduced new constraints on rebate retention structures
Bacteriostatic Water Storage: The Temperature Threshold That Changes Everything Here's what the FDA-registered 503B facilities don't emphasize enough: the question of whether BAC water needs refrigeration has two completely different answers depending on one variable